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http://www.trialsjournal.com/content/15/1/71STUDY PROTOCOL Open AccessImproving coronary heart disease self-management
using mobile technologies (Text4Heart): a
randomised controlled trial protocol
Leila Pfaeffli Dale1*, Robyn Whittaker1, Yannan Jiang1, Ralph Stewart2, Anna Rolleston3 and Ralph Maddison1Abstract
Background: Cardiac rehabilitation (CR) is a secondary prevention program that offers education and support to
assist patients with coronary heart disease (CHD) make lifestyle changes. Despite the benefits of CR, attendance
at centre-based sessions remains low. Mobile technology (mHealth) has potential to reach more patients by
delivering CR directly to mobile phones, thus providing an alternative to centre-based CR. The aim of this trial
is to evaluate if a mHealth comprehensive CR program can improve adherence to healthy lifestyle behaviours
(for example, physically active, fruit and vegetable intake, not smoking, low alcohol consumption) over and above
usual CR services in New Zealand adults diagnosed with CHD.
Methods/design: A two-arm, parallel, randomised controlled trial will be conducted at two Auckland hospitals
in New Zealand. One hundred twenty participants will be randomised to receive a 24-week evidence- and
theory-based personalised text message program and access to a supporting website in addition to usual CR
care or usual CR care alone (control). The primary outcome is the proportion of participants adhering to healthy
behaviours at 6 months, measured using a composite health behaviour score. Secondary outcomes include
overall cardiovascular disease risk, body composition, illness perceptions, self-efficacy, hospital anxiety/depression
and medication adherence.
Discussion: This study is one of the first to examine an mHealth-delivered comprehensive CR program. Strengths of
the trial include quality research design and in-depth description of the intervention to aid replication. If effective,
the trial has potential to augment standard CR practices and to be used as a model for other disease prevention or
self-management programs.
Trial registry: Australian New Zealand Clinical Trials Registry: ACTRN12613000901707
Keywords: Cardiovascular disease, Health behaviour, Lifestyle change, mHealth, Text messagingBackground
Unhealthy lifestyle behaviours, including smoking, phys-
ical inactivity, hazardous alcohol consumption and low in-
take of fruit and vegetables have been shown to contribute
to the development of coronary heart disease (CHD) [1,2],
which remains a leading cause of death worldwide [3].
Lifestyle modifications are encouraged for secondary pre-
vention of CHD. Cardiac rehabilitation (CR) is a cost-
effective program of education and support designed to* Correspondence: l.pfaeffli@nihi.auckland.ac.nz
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unless otherwise stated.assist patients make healthy lifestyle changes and adhere
to clinical guidelines, and it is associated with reduced
mortality and hospitalisations [4-7]. Recommended life-
style changes can include starting and maintaining regular
exercise, eating a heart-healthy diet, stopping smoking, ad-
hering to prescribed medication regimens and attending
medical appointments [8-10].
Inviting patients hospitalised for CHD to attend centre-
based CR is usual care in most developed countries, in-
cluding New Zealand, yet attendance rates remain low
[11-13]. Barriers to attending CR include limited transpor-
tation and parking availability, inconvenient scheduling of
CR sessions, language-related communication difficultiesd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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delivery methods of CR are required to better meet pa-
tients’ needs.
Delivering CR using mobile technologies, known as
mHealth, has the potential to overcome such barriers, as
programs can be personalised and delivered anywhere
and at any time. mHealth interventions have successfully
been shown to have a positive effect on health behav-
iours, such as smoking cessation and improvement in
disease self-management [17,18]; however, mHealth in a
CHD population has not been thoroughly investigated to
date. The recently completed Heart Exercise and Remote
Technologies (HEART) trial (N = 171) demonstrated
that a simple text message and Internet intervention was
effective in general as well as cost-effective for increasing
leisure time physical activity and walking, but not for in-
creasing maximal oxygen uptake in people with CHD at
6 months after randomisation [19,20]. Moreover, qualita-
tive data indicated that the HEART intervention was
well-received, had positive effects on participants’ phys-
ical activity levels and was not considered burdensome
[21]. Whilst HEART demonstrated the feasibility and ef-
fectiveness of implementing a mobile telephone interven-
tion, it focused on only a single behaviour (exercise) [22].
To build on this work, we propose testing the effective-
ness of a comprehensive mHealth self-management inter-
vention to enhance patients’ lifestyles.
Previous studies in which investigators targeted mul-
tiple risk factors often measured only one behaviour ra-
ther than the overall effect of the intervention [23].
Evaluating the combined effect of the intervention to
change multiple behaviours is important, as many CHD
patients have more than one lifestyle-related risk factor.
The primary aim of our present trial (Text4Heart) is to
evaluate the effectiveness of a comprehensive mHealth
CR program in improving adherence to recommended
lifestyle behaviour guidelines at 6 months after random-
isation, in addition to usual CR care. Secondary objec-
tives include the effect of 6 months of the intervention
on overall cardiovascular (CVD) risk, body composition,
illness perceptions, medication adherence, self-efficacy
and hospital anxiety and/or depression.Methods/design
This protocol describes a six-month, two-arm, parallel,
randomised controlled trial to evaluate an mHealth-
delivered comprehensive (that is, multiple health behav-
iour) CR intervention in adults with CHD on the basis
of a composite health behaviour score. The protocol is
in accord with the SPIRIT 2013 statement [24], and the
intervention is described according to the CONSORT-
EHEALTH checklist [25]. See Additional file 1 for the
complete checklist.Study sample and recruitment
Eligible participants are English-speaking New Zealand
adults (ages 18 years and older) with a documented diag-
nosis of CHD (myocardial infarction (MI), angina or
revascularisation) who meet the criteria for usual CR
care and have access to the Internet (for example, li-
brary, work or home access). A basic mobile telephone
with which to receive text messages will be available on
loan to participants who do not own one (fewer than
one in ten New Zealanders). Exclusion criteria are un-
treated ventricular tachycardia, severe heart failure, life-
threatening coexisting disease with life expectancy less
than 1 year, and/or significant exercise limitations for
reasons other than CHD.
Potential participants will be screened during hospital
admission at two metropolitan hospitals in Auckland,
New Zealand. The annual incidence of hospitalisation
for CHD in New Zealand overall is approximately 162
people per 100,000 [26] and over 2,400 in the Auckland
area. The recruitment strategy was effective in the
HEART trial [20,21]. Potential participants will receive a
study information sheet while in hospital, and informed
consent will be obtained from participants at the baseline
assessment. All patients will be offered usual CR care.
Assessments will be conducted in hospital, community
clinics or participants’ homes to encourage retention.
Outcome assessments
Assessments will be conducted at baseline and 6 months
postrandomisation (see Figure 1). Baseline assessments will
involve an explanation of study procedures, signed consent
and collection of demographic details. Participant-reported
primary and secondary outcomes will then be collected,
followed by physical measurements, including height,
weight, waist and hip circumference, blood pressure and
blood cholesterol. The baseline assessment concludes with
randomisation and assignment of participants to the re-
spective study groups.
Ethical approval
Ethical approval was obtained from the Health and Disabil-
ity Ethics Committee (13/NTA/6). Each hospital research
committee also approved the study. Serious adverse events
will be collected at 12 weeks and 6 months and will be re-
ported to the ethics committees along with any protocol
amendments or violations.
Sample size
One hundred twenty participants (sixty per group) will
provide at least 80% power at the 5% level of significance
(two-sided) to detect an absolute difference of 25% be-
tween the two groups, in the proportions of participants
adherent to recommended healthy behaviour guidelines
(that is, not smoking, low alcohol consumption, fruit
6-MONTH ASSESSMENT
-Height and weight
-Blood pressure and cholesterol
-Waist and Hip circumference
- Lifestyle Questionnaires (nutrition, 
smoking, AUDIT C, GLTPAQ)
- Well-being questionnaire: Brief IPQ, 
HADS, self-efficacy
- MMAS and concomitant medication
- Adverse events
6-month 
Follow-up 
Assessment
MHEALTH INTERVENTION 
GROUP (n=60)
- 24 week text message program 
and access to website
- Standard CR services
- 3-month phone call
CONTROL GROUP
(n=60)
-Standard CR services
- 3-month phone call
Potential participants screened during 
hospital admission for CHD. Baseline 
assessment conducted within 3 weeks of 
hospital discharge
BASELINE ASSESSMENTS
- Eligibility confirmed & informed consent 
obtained
- Demographics
- Height and weight
-Blood pressure and cholesterol
- Waist and Hip circumference
- Lifestyle Questionnaires (nutrition, 
smoking, AUDIT C, GLTPAQ)
-Well-being questionnaire: Brief IPQ, HADS, 
self-efficacy
Baseline 
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Screening 
RANDOMISATION
Figure 1 Flow diagram of the study protocol. AUDIT C: Alcohol Use Disorders Identification Test alcohol consumption questions;
Brief IPQ: Brief Illness Perception Questionnaire; CHD: Coronary heart disease; CR: Cardiac rehabilitation; GLTPAQ: Godin Leisure Time Physical
Activity Questionnaire; HADS: Hospital Anxiety and Depression Scale; MMAS: Morisky 8-item Medication Adherence Scale.
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6 months after randomisation.
The sample size calculation was based on data from
the EPIC-Norfolk Prospective Population Study, in
which the investigators used a composite health behav-
iour score to determine the relationship between lifestyle
and total mortality by cause in adults between 45 and
79 years of age living in the general community [27].
Given our population of people with established CHD,
we estimate that 30% to 40% of our sample will be ad-
herent to healthy behaviour guidelines at baseline [27].
Randomisation and blinding
Following baseline data collection, eligible and consented
participants will be randomised to either the intervention
group or the control group in a 1:1 ratio. The randomisa-
tion sequence will be generated by using a computer pro-
gram in blocks of six and will be overseen by the project
statistician and unavailable to outcome assessors. Ran-
domisation will be stratified according to smoking status(smoker vs. nonsmoker) to help balance baseline health
behaviour scores. Allocation will be concealed in consecu-
tively numbered, opaque sealed envelopes. Owing to the
nature of the intervention, participants will be aware of
the group to which they have been assigned; however, at
follow-up, outcome assessors will be blinded to the treat-
ment allocation.
Standard cardiac rehabilitation care
All participants will be offered the standard outpatient
CR program provided by each hospital, which involves
education classes and supervised exercise.
Study intervention
In addition to standard CR care, the mHealth interven-
tion group will receive the core components of CR deliv-
ered via text messages (also known as short messaging
service (SMS)) and a supporting website over the course
of 24 weeks. The intervention will be delivered primarily
by SMS because SMS is readily available to all mobile
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pants will be offered brief training in how to use SMS
and the Internet if necessary. Each intervention partici-
pant will receive a NZ$20 telephone credit voucher to
reimburse any costs associated with replying to interven-
tion messages. No changes will be made to the interven-
tion or study design once recruitment begins; however,
participants can choose to stop receiving the interven-
tion and will be informed of this option during the con-
sent process. A SMS library of 503 messages has been
developed. It is written in English at an appropriate read-
ing level (RMS 800 Lexile: approximately age 13 years)
tested using the Lexile Analyzer 2013 software program
(MetaMetrics, Durham, NC, USA). Intervention partici-
pants will receive five to seven messages per week for
24 weeks.
The overall goals of the intervention are to have individ-
uals adhere to clinician-prescribed New Zealand CHD
treatment [8] and American College of Sports Medicine
guidelines [28]. Intervention content is based on the
current CR guidelines, previous trials [19,29,30] and devel-
opmental studies. Content will be delivered on two aspects
of self-management to improve participants’ condition and
manage the emotional distress often associated with CHD:
illness perceptions and lifestyle changes.
Illness perceptions
Messages will address illness perceptions and medication-
related beliefs using the Common-Sense Model [31]. The
intervention will focus on modifying people’s perceptions
of treatment for secondary prevention of CHD with regard
to symptoms, timelines, causes, consequences, understand-
ing of CHD treatment, personal control over CHD treat-
ment and the effectiveness of CHD treatment. A lower
perceived threat of illness has been shown to predict CR
attendance and return to work in MI patients [32].
Messages will contain information and strategies to help
participants stick to their prescribed medication regimen,
information on the value of taking medication in terms of
reducing subsequent events and hospitalisation, and re-
minders to have a regular checkup with their physicians.
Lifestyle changes
The intervention includes education and support to eat
a healthy diet, manage stress, exercise regularly, reduce
alcohol consumption and stop smoking (if needed).
Additional SMS will be delivered based on the subopti-
mal behaviour participants most wish to modify (out-
lined below), which will be identified at the baseline
assessment.
Physical activity
Content was adapted from the HEART trial, and mes-
sages will be sent regarding the importance of beingphysically active, suggested activities and key strategies
(for example, goal-setting and self-monitoring) to en-
hance uptake and maintenance of physical activity. Gen-
eral exercise prescription will be offered, detailing the
type, frequency, duration and intensity of exercise based
on participants’ preferred activities [28]. A pedometer
will be provided to participants in the intervention
group to assist with self-monitoring of daily activity.
Heart healthy diet
Participants will be supported to eat a heart-healthy diet
and manage their weight. This support will include large
servings of fruits and vegetables, whole grains, lean
meats and alternatives while limiting intake of saturated
fat, salt, alcohol and sugar [8]. Participants will receive
text messages promoting healthy eating strategies, over-
coming barriers and advice on choosing healthy food
and food preparation.
Stress management
Participants will receive education to improve their quality of
life through the identification and treatment of psychological
distress. Treatment includes learning relaxation techniques
and specific coping strategies to be used during times of
stress, as well as avoiding harmful behaviours (that is, alcohol
consumption). Strategies will be emphasised that facilitate
participants’ return to a full and active life by enabling the
development of their own resources. A health psychologist
has aided in the development of these messages.
Stopping smoking
Participants who smoke tobacco will receive compo-
nents of successful cessation interventions by text mes-
saging [33] and video messaging [29]. They will be sent
regular messages providing smoking cessation advice
and support (for example, symptoms to expect upon
quitting, tips to avoid weight gain during and after cessa-
tion and to cope with craving, and advice on avoiding
smoking triggers).
The lifestyle change component is framed by social
cognitive theory (SCT) [34]. A key construct of SCT is
self-efficacy, or the confidence to engage in a desired be-
haviour, which has been shown to be a mediator of be-
haviour change [35] and is an outcome of CR [36].
Specific behaviour change techniques (BCTs) [37] that
have been reported to be effective in changing health be-
haviours in a CHD population [38,39] will be used to
target the constructs of SCT. All text messages are
coded according to their SCT construct and related
BCTs (see Additional file 2 for a sample).
Supporting website
A secondary component of the intervention is a secure sup-
porting website (Text4Heart homepage, https://text4heart.
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tation.org/6KNUFTSwm; see Additional file 3 for screen-
shots). A number of interactive features have been created
to increase interactivity and website usage [30]. The website
includes a blog whereby participants can ask questions and
receive answers and social support, as well as a graph with
which participants can monitor their physical activity by
texting their pedometer counts, which will then be auto-
matically uploaded. Additional information will be provided
regarding CR, taking medications, various forms of physical
activity, healthy eating, smoking cessation and hyperlinks to
other websites (for example local exercise programs and
cardiac clubs).
Efficacious beliefs can be enhanced through the use of
vicarious learning, or role modelling, which refers to the
process of learning behaviours by viewing other people’s
behaviours and the outcomes of those behaviours [36].
Role modelling will be incorporated into the interven-
tion through the use of short videotape messages (30 to
60 seconds) on the participant website. The video clips
will involve a variety of CHD patients discussing their
experiences of lifestyle change, the types of problems
they faced, how they coped and any advice they can
offer. Brief vignettes outlining the benefits of CR and
healthy lifestyles, physiological responses, and safety issues
will be provided by exercise scientists, nutritionists and
cardiologists. Participants will receive occasional text mes-
sages (approximately once per fortnight) prompting them
to view the website.
Tailoring
A recent mHealth review found that personalised inter-
ventions were more effective at changing behaviour;
however, few study researchers had implemented tailored
components [17]. The Text4Heart intervention is perso-
nalised according to each participant’s name, choice of
suboptimal behaviour and the time of day messages are
sent. Bidirectional messages are included that require the
participant to respond, such as texting in pedometer step
counts, which then trigger a tailored response from the
study team. Participants will be able to ‘text an expert’ to
request personalised feedback, with questions answered
by the researchers within 48 hours. This dynamic feedback
loop holds promise to improve health behaviour, as rapid
two-way communication provides participants with just-
in-time information or strategies [40]. The intervention is
designed to be automated and thus minimize human in-
volvement; however, participants will be encouraged to
connect with a real person (study team member) to ask
questions if needed.
The corresponding author is responsible for monitor-
ing the website and responding to incoming text mes-
sages from participants, as well as for updating the video
page and blog with news and tips twice per week. Theonly planned personal contact from the study team will
occur at 12 weeks after randomisation, when a member
of the research team will telephone participants to re-
mind them about the study, check on their progress
against goals and answer any questions. Both the inter-
vention and control groups will receive this telephone
call to ensure that any between-group differences are the
result of the text messages and the website, not human
contact. The multifaceted approach of personalised
SMS, videotape messages, website usage and opportun-
ities for telephone contact may better encourage disease
self-management than a unifaceted, SMS-only interven-
tion [41].
Primary outcome
The primary outcome is adherence to recommended life-
style behaviours, which will be measured using a compos-
ite health behaviour score adapted from the EPIC-Norfolk
Prospective Population Study [27]. In the present study,
the measures described below will be used to determine
participants’ health behaviour scores.
1. Smoking status will be measured using a common
smoking history questionnaire [42]. This eight-item
questionnaire is used to assess smoking status
(current smoker, ex-smoker or nonsmoker), the
number of cigarettes smoked per day and history of
quit attempts.
2. Physical activity level will be assessed using the
Godin Leisure Time Physical Activity Questionnaire
(GLTPAQ) [43]. This simple three-item questionnaire
has well-established reliability and validity and has
been used in patients undergoing CR (N = 826) [44].
3. Alcohol consumption will be measured using the
Alcohol Use Disorders Identification Test alcohol
consumption questions (AUDIT-C) [45], a screening
tool designed to assess units of alcohol consumed
per week and to identify people who are hazardous
drinkers. The AUDIT-C has been used as a primary
care screening test for alcohol dependence in a
sample of 243 older men with medical conditions,
including heart disease [45]. Index cards referencing
standard drink sizes will be used to reduce
comprehension errors.
4. Fruit and vegetable intake will be assessed by two
New Zealand–specific questions used in the 2006/
2007 New Zealand Health Survey (N = 12,488,
including adults with CHD) [46]. Index cards
referencing standard fruit and vegetable serving
sizes will be used to aid recall.
Participants will receive a score on a four-point scale,
with one point each assigned for being a current non-
smoker, meeting physical activity guidelines to achieve
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GLTPAQ), consuming fourteen or fewer standard alco-
holic drinks per week [27] and consuming at least five
servings of fruits and vegetables per typical day [27].
Secondary outcomes
The following are the secondary outcomes of the
present study.
1. We will measure the difference in absolute CVD risk
score [47] at 6 months after randomisation. This
measure was developed for predicting risk in people
with previous CVD events, but has also been applied
to secondary prevention populations as a composite
measure of changes in risk factors. The individual
risk factors that form the absolute CVD risk score
include age, lipid levels, blood pressure, and smoking
and diabetes status.
2. Body composition will be measured using body mass
index and waist-to-hip ratio. Physical measurements
will be taken as the average of two readings.
3. Illness perceptions will be assessed using the Brief
Illness Perception Questionnaire (B-IPQ) [48]. The
B-IPQ has been used in a cardiac setting to examine
speed of recovery following MI [32]. Items are
scored on scales from zero to ten and can be
collapsed into smaller clusters of causal beliefs.
When items are combined, a higher score represents
a more threatening perception of the participant’s
disease.
4. Self-reported medication adherence will be assessed
using the Morisky 8-item Medication Adherence
Scale (MMAS) [49]. The MMAS has been used in a
sample of patients with hypertension and has been
found to predict reasons for poor adherence [50]. It
will be completed at the 6-month assessment, as
at baseline participants may not yet have been
discharged from hospital with their new medications.
Items are answered as yes or no, and scores are
combined to indicate low, medium and high
medication adherence. A list of participants’
prescribed medications will also be collected.
5. Self-efficacy will be assessed using the Self-efficacy
for Managing Chronic Disease 6-item Questionnaire
[51]. This six-item questionnaire has well-established
reliability and validity on the basis of its use in a
sample of participants with chronic disease, including
heart disease (N = 1,130). Items are scored from one
to ten, with a higher combined score indicating higher
self-efficacy.
6. Mood will be assessed using the Hospital Anxiety
and Depression Scale (HADS) [52]. The HADS
performed well in assessing anxiety disorders and
depression in somatic, psychiatric and primary carepatients as well as in the general population.
Participants will be asked to choose one of four
answers to each item (six items for depression and
six for anxiety). Each answer is assigned a score and
added up to determine the indicated normal to
abnormal levels of anxiety and/or depression.
7. Engagement in the intervention (for example,
number of messages read, visits to the study website
and number of contacts with the study team) will be
assessed in exit surveys and on the basis of website
usage statistics gathered by a website visit tracking
system.
Statistical analyses
Treatment evaluation will be performed on the principle
of intention to treat. Statistical analyses will be con-
ducted using SAS version 9.3 software (SAS Institute,
Cary, NC, USA). The present study is a standard two-
arm equality trial; therefore, all statistical tests will be
two-sided and maintained at a 5% significance level.
Demographics and baseline characteristics of all rando-
mised participants will be summarized for each group as
well as overall. Continuous variables will be reported as
mean ± SD. Categorical variables will be reported as
numbers (%).
Simple χ2 analyses will be used to evaluate the main
treatment effect on the proportion of participants adher-
ent to health behaviours at end of the intervention
period, with estimation of relative risks, 95% confidence
intervals and two-sided P-values. We hypothesise that
the proposed intervention will change the proportion of
participants adherent to recommended healthy behav-
iour guidelines at 6 months after randomisation by at
least 25% compared with the control group. Multiple re-
gression analysis appropriate for binary and continuous
outcome measures will be conducted to evaluate the
treatment effects, adjusting for important confounding
factors at baseline. All analyses for secondary outcomes
will be exploratory.
Discussion
The Text4Heart trial will evaluate a comprehensive
mHealth CR intervention to improve adherence to life-
style behaviours. To the best of our knowledge, this is
the first mHealth study to assess multiple behaviours
using a composite score and one of the first to evaluate
a comprehensive mHealth self-management intervention
in adults with CHD. The protocol, in accordance with
the SPIRIT statement, incorporates findings from recent
mHealth systematic reviews with the aim of adding qual-
ity evidence to the body of literature.
Common criticisms have been voiced regarding mHealth
research designs and trial descriptions [41,53]. Few ad-
equately powered randomised controlled trials have been
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sessments are often not long enough, as it takes approxi-
mately 6 months for participants to adopt new behaviours
[54]. The Text4Heart trial has been developed with these
concerns in mind, and therefore we have incorporated a
randomised controlled trial design with a 6-month follow-
up period.
Many mHealth studies also fail to fully describe their
interventions, in particular the behaviour change theory
or BCTs used, if any, and the evidence behind the con-
tent of the intervention [25,53]. mHealth studies often
offer insufficient explanation of the intervention for its
design to be replicated [25]. This is a particular concern
because mHealth technology changes rapidly, and it is
important to know which aspects of an intervention
worked and which did not. The Text4Heart study proto-
col describes the intervention in full, including the theor-
etical framework and examples of SMS and Internet
content. The intervention incorporates knowledge learned
from previous mHealth research and has involved the tar-
get audience in the content development stage of the
intervention.
On the basis of earlier results, it is evident that the
CHD population in New Zealand is interested in
mHealth CR and is able to use the related technology
[20,55]. If effective, the trial has the potential to be im-
plemented in a CR setting and to be used as a model for
other disease prevention and self-management pro-
grams. The intervention could easily be augmented to
provide opportunities for clinicians to engage in two-
way communication with patients regarding their life-
style behaviours, as well as clinical outcomes such as
monitoring blood pressure and weight. This study will
provide data on the potential of mHealth to improve pa-
tient care.
Trial status
The trial is currently open for recruitment.
Additional files
Additional file 1: SPIRIT 2013 Checklist. The SPIRIT checklist lists items
to be included in the protocol. All items are accounted for either in the
manuscript or in this file.
Additional file 2: Example of text message content and related
social cognitive theory (SCT) construct and behaviour change
techniques (BCTs). This table provides examples of intervention content
and the related theoretical constructs.
Additional file 3: Text4Heart study website screenshots. This
document provides screenshots of the Text4Heart participant website.
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